Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old

Clinical trial NCT07621341 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07621341
Sponsor: Chiang Mai University
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Pertussis Diphtheria Tetanus Vaccine-Preventable Diseases

Start date: 2026-05-26
Primary completion: 2029-12-31
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.